The current price of NDRA is $5.01 — it has increased by 1.32% since the previous close. Data as of Nov 5, 2026.
NDRA is up 3.20% over the past week, down 20.68% over the past month and down 3.93% over the past year. The price is above its 200-day moving average of $4.81.
Of the 1 analyst covering ENDRA Life Sciences Inc., 1 rates it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
ENDRA Life Sciences Inc. has a market capitalization of $7.51M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, ENDRA Life Sciences Inc. posted a loss of $0.63 per share against an estimate of -$0.84, beating expectations by 25.00%. Upcoming reports are listed in the earnings calendar.
ENDRA Life Sciences Inc. has not paid any dividends over the past year.
Companies most comparable to ENDRA Life Sciences Inc. include Corvex, Inc., HeartSciences Inc., Bio Green Med Solution, Inc., iSpecimen Inc. and NanoVibronix, Inc.
In the latest trading session NDRA moved between $4.00 and $5.01, a range of 20.08% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of ENDRA Life Sciences Inc. shows a neutral rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for ENDRA Life Sciences Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks NDRA has traded between $2.96 and $6.95. The current price is 27.99% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.